Indian Imipenem Exporters: Complete Supplier Ranking with Market Share — 140 Manufacturers (2026) — TransData Nexus

Q: Who is the largest imipenem supplier from India?

VENUS REMEDIES LIMITED is the largest imipenem exporter from India with a 40.6% market share and export value of $13.5M.

Q: How many imipenem suppliers are there in India?

There are 140 active imipenem exporters in India, collectively shipping $33.3M worth of imipenem across 803 shipments according to Indian Customs (DGFT) records.

Q: What is the market share of top imipenem suppliers from India?

The top 5 imipenem suppliers from India — VENUS REMEDIES LIMITED, SUN PHARMACEUTICAL INDUSTRIES LIMITED, SWISS PARENTERALS LIMITED, SUN PHARMACEUTICAL INDUSTRIES LTD, PROTECH BIO SYSTEMS PRIVATE LIMITED — together control 79.7% of total imipenem export value from India.

Suresh Sormare

Imipenem

India Pharmaceutical Trade Intelligence

$33.3M140 Suppliers94 CountriesHS 30049099

ExportsIndia → MEXICO27.2%India → BELGIUM10.0%

ImportsUNITED KINGDOM → India$131.3K UNITED STATES → India$111.3K

#1 Supplier: VENUS REMEDIES

Imipenem Suppliers from India (2026) — 140 Exporters, $33.3M Market | TransData Nexus | TransData Nexus

Who Exports Imipenem from India — 140 Suppliers Behind a $33.3M Market

India's imipenem export market is supplied by 140 active exporters who collectively shipped $33.3M across 803 shipments. VENUS REMEDIES LIMITED leads with a 40.6% market share, followed by SUN PHARMACEUTICAL INDUSTRIES LIMITED and SWISS PARENTERALS LIMITED. The top 5 suppliers together control 79.7% of total export value, reflecting a concentrated market structure.

Source: Indian Customs (DGFT)·Published March 2026

India's Top Imipenem Suppliers & Exporters — 140 manufacturers, $33.3M export market, top destinations and formulations — Imipenem supplier data — 140 exporters · $33.3M market · 803 shipmentsTransData Nexus · Indian Customs Data

Top Imipenem Exporters from India — Ranked by Export Value

VENUS REMEDIES LIMITED is the leading imipenem exporter from India, holding a 40.6% share of the $33.3M market across 803 shipments from 140 exporters. The top 5 suppliers — VENUS REMEDIES LIMITED, SUN PHARMACEUTICAL INDUSTRIES LIMITED, SWISS PARENTERALS LIMITED, SUN PHARMACEUTICAL INDUSTRIES LTD, PROTECH BIO SYSTEMS PRIVATE LIMITED — collectively control 79.7% of total export value, indicating a highly concentrated market. Individual shares are: VENUS REMEDIES LIMITED (40.6%), SUN PHARMACEUTICAL INDUSTRIES LIMITED (24.9%), SWISS PARENTERALS LIMITED (6.3%), SUN PHARMACEUTICAL INDUSTRIES LTD (4.0%), PROTECH BIO SYSTEMS PRIVATE LIMITED (4.0%).

Top Imipenem Exporters from India

Ranked by export value · 140 active suppliers · Indian Customs (DGFT) data

Mar 2026

Top Imipenem Exporters from India — Ranked by Export Value. 140 active suppliers with export value, shipments, countries and formulations data compiled from Indian Customs records by TransData Nexus.
#	Supplier & Formulations	Value	Ships.	Ctry.	Share
1

Supplier Certification & Compliance Matrix

FDA, WHO-GMP, and EU GMP status for top Imipenem exporters

Certification and compliance status for top Imipenem suppliers from India
Supplier	US FDA	WHO-GMP	EU GMP	ANDAs	Notes
Venus Remedies Limited	QIDP designation for VRP-	Yes	Yes	Not verified	Received QIDP designation from FDA for VRP-034 in April 2025.
Sun Pharmaceutical Industries Limited	Approved	Yes	Yes	Not verified	FDA-approved manufacturer with WHO and EU GMP certifications.
Swiss Parenterals Limited	Not Listed	Yes	No	Not verified	WHO GMP certified; no FDA listing found.
Baxter Pharmaceuticals India Private Limited	Approved	Yes	Yes	Not verified	FDA-approved manufacturer with WHO and EU GMP certifications.
Jodas Expoim Private Limited	Not Listed	Yes	No	Not verified	WHO GMP certified; no FDA listing found.
Kwality Pharmaceuticals Limited	Not Listed	Yes	No	Not verified	WHO GMP certified; no FDA listing found.
Marksans Pharma Limited	Approved	Yes	Yes	Not verified	FDA-approved manufacturer with WHO and EU GMP certifications.
M J Biopharm Private Limited	Not Listed	Yes	No	Not verified	WHO GMP certified; no FDA listing found.

TransData Nexus reviewed the regulatory standing of 8 leading Imipenem exporters from India. 3 hold US FDA facility approvals, 8 maintain WHO-GMP certification, and 4 are EU GMP compliant. For regulated markets (US, EU, Australia), prioritise suppliers with active FDA or EU GMP approvals. For semi-regulated markets (Africa, ASEAN, Latin America), WHO-GMP certification is the minimum recommended standard.

Certification status compiled from publicly available regulatory databases including FDA Orange Book, WHO Prequalification database, and EMA GMP registry. Buyers should independently verify compliance status with the relevant regulatory authority before placing orders.

TransData Nexus Research · Mar 2026

Manufacturing Hub Analysis — Vendor Proximity

India's pharmaceutical clusters relevant to Imipenem sourcing

1Hyderabad — Bulk Drug Capital

Hyderabad, often referred to as the "Bulk Drug Capital of India," is a major hub for the production of active pharmaceutical ingredients (APIs). The city hosts numerous manufacturing facilities that contribute significantly to India's API output. Companies such as Granules India Limited, headquartered in Hyderabad, specialize in the manufacture and sale of APIs, pharmaceutical formulation intermediates, and finished dosage forms. Their product portfolio includes essential drugs like Paracetamol, Metformin, and Guaifenesin.

2Ahmedabad-Vadodara — Formulations Hub

The Ahmedabad-Vadodara corridor in Gujarat is renowned for its focus on pharmaceutical formulations. This region is home to prominent companies like Alembic Pharmaceuticals, headquartered in Vadodara. Alembic Pharmaceuticals manufactures and markets a wide range of pharmaceutical products, including APIs and formulations, with a presence in the macrolide anti-infective drug segment. Their operations encompass manufacturing facilities in Gujarat and research and development centers in India and the United States.

3Mumbai-Thane-Raigad — Export Gateway

Recent M&A, Collaborations & Capacity Expansions

Industry developments among top Imipenem exporters from India

June 2023

M&A

Sun Pharmaceutical Industries Limited — Sun Pharma acquires 60% stake in Vivaldis Health and Foods

In June 2023, Sun Pharmaceutical Industries Limited completed the acquisition of a 60% shareholding in Vivaldis Health and Foods Private Limited for ₹1,433.2 million. - IMPACT: This acquisition is expected to enhance Sun Pharma's product portfolio, potentially influencing its Imipenem export capabilities.

Impact: This acquisition is expected to enhance Sun Pharma's product portfolio, potentially influencing its Imipenem export capabilities.

TransData Nexus Industry Research · Regulatory filings and press releases · Mar 2026

Common Questions — Imipenem Suppliers from India

Answers based on Indian Customs (DGFT) shipment records compiled by TransData Nexus

Q Which imipenem supplier from India is the most reliable for bulk orders?

Based on shipment frequency and export consistency, VENUS REMEDIES LIMITED leads with 194 recorded shipments worth $13.5M. SUN PHARMACEUTICAL INDUSTRIES LIMITED (119 shipments) and SWISS PARENTERALS LIMITED (9 shipments) are also established high-volume exporters.

Q How many imipenem manufacturers are there in India?

India has 140 active imipenem exporters with a combined export market of $33.3M across 803 shipments to 94 countries. The top 5 suppliers hold 79.7% of total export value.

Q What certifications should I verify?

Verify: WHO-GMP certification (most markets), US FDA approval (United States), EU GMP certificate (EU/EEA), and Free Sale Certificate from CDSCO. Always request a Certificate of Analysis (CoA) and Certificate of Origin (CoO).

Q What is the typical price range for imipenem from India?

Average FOB unit price: $4.71 per unit, ranging from $0.08 to $119.08. Average shipment value: $41.5K.

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Imipenem

Imipenem

Who Exports Imipenem from India — 140 Suppliers Behind a $33.3M Market

Top Imipenem Exporters from India — Ranked by Export Value

Top Imipenem Exporters from India

Related Analysis

Need Details?

Supplier Certification & Compliance Matrix

Manufacturing Hub Analysis — Vendor Proximity

1Hyderabad — Bulk Drug Capital

2Ahmedabad-Vadodara — Formulations Hub

3Mumbai-Thane-Raigad — Export Gateway

Recent M&A, Collaborations & Capacity Expansions

Sun Pharmaceutical Industries Limited — Sun Pharma acquires 60% stake in Vivaldis Health and Foods

Common Questions — Imipenem Suppliers from India

Q Which imipenem supplier from India is the most reliable for bulk orders?

Q How many imipenem manufacturers are there in India?

Q What certifications should I verify?

Q What is the typical price range for imipenem from India?

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Primary Data Source

4Baddi-Nalagarh — Tax Incentive Zone

5Sourcing Recommendations

Analysis Methodology